Compound Detail
CHEMBL566043
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Cc1c(CN(C)C(=O)/C=C/c2cnc3c(c2)CN(CCN2CCOCC2)C(=O)N3)sc2ccccc12
Basic Information
| ChEMBL ID | CHEMBL566043 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | LWQRVEMDGXOEIR-BQYQJAHWSA-N |
2
Targets
2
Activities
1
Assay Types
0
PK Parameters
5
Publications
0
Known Names
Molecular Properties
505.6
MW (Da)
3.96
ALogP
6
HBA
1
HBD
78.0
PSA (Ų)
0.49
QED
1
Ro5 Violations
7
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 2 meas. best 8.15
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Enoyl-[acyl-carrier-protein] reductase [NADH] FabI CHEMBL1857 | IC50 | 8.15 | 8.15 | 7.0 | 1 |
| Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI CHEMBL3994 | IC50 | 7.58 | 7.58 | 26.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Enoyl-[acyl-carrier-protein] reductase [NADH] FabI | IC50 | = | 7.0 | nM | 8.15 | Inhibition of Escherichia coli FabI assessed as effect on NAD(P)H consumption | 19682901 |
| Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI | IC50 | = | 26.0 | nM | 7.58 | Inhibition of Staphylococcus aureus FabI | 19682901 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 19682901 | 10.1016/j.bmcl.2009.07.129 | No relevant target | 2 |
| 19682901 | 10.1016/j.bmcl.2009.07.129 | Staphylococcus aureus | 2 |
| 19682901 | 10.1016/j.bmcl.2009.07.129 | Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI | 1 |
| 19682901 | 10.1016/j.bmcl.2009.07.129 | Escherichia coli | 1 |
| 19682901 | 10.1016/j.bmcl.2009.07.129 | Enoyl-[acyl-carrier-protein] reductase [NADH] FabI | 1 |
Data from ChEMBL 36 via Core Engine